by U.S. Medicine
The rapid expansion of treatment options for advanced or metastatic renal cell carcinoma (RCC) in the last decade has improved survival rates and brought hope to the one-third of RCC patients diagnosed with Stage IV cancer.
by Brenda Mooney
Improved treatment has meant better overall survival for many men diagnosed with prostate cancer, according to a new research letter. For older patients, however, the benefits of the new therapies weren’t as effective, the authors pointed out.
by Stephen Spotswood
Recent data from DoD seems to confirm what researchers and physicians have been saying for years—that individuals who receive the COVID-19 vaccine are less likely to experience long-term health effects than those who do not.
by U.S. Medicine
How often does local recurrence occur in hepatocellular carcinoma (HCC) patients who undergo selective transarterial radioembolisation (TARE) or transarterial chemoembolisation (TACE) and achieve a complete response (CR) radiologically?
by U.S. Medicine
It can be difficult to determine which patients with cirrhosis will go on to develop hepatocellular carcinoma (HCC).